À retenir
In PREDIMED (7447 high-risk adults), good Mediterranean diet adherence including wine was linked to lower cardiovascular disease (HR 0.55; 95% CI 0.36-0.83) and all-cause mortality (HR 0.67) versus poor adherence, more than without wine (HR 0.84, not significant, and 0.77). Analyses least prone to abstainer bias and interaction tests were not significant, and the younger SUN cohort showed no significant CVD link.
Study design
Essai randomisé
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
The Mediterranean diet is well established as healthy, but wine, one of its components, is controversial. The authors asked whether the diet's links to cardiovascular disease and death differ depending on whether the wine item is counted.
Population et méthode
Two Spanish cohorts. PREDIMED included 7447 high-risk participants; Mediterranean diet adherence was measured with a validated 14-item questionnaire, including one wine item (cut-off seven glasses per week). Cardiovascular events were recorded over a 4.8-year follow-up and all-cause mortality over 17 years. The SUN project, a younger cohort of 23,133 participants followed for 22 years, was also assessed. Results are multivariable-adjusted hazard ratios (HR) comparing good with poor compliers.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1PREDIMED, cardiovascular disease: good compliers excluding wine had HR 0.84 (95% CI 0.61-1.15, not significant); including wine, HR 0.55 (95% CI 0.36-0.83).
- 2PREDIMED, all-cause mortality: HR 0.77 (95% CI 0.68-0.87) excluding wine and 0.67 (95% CI 0.57-0.78) including wine. In exploratory dose-response analyses, the lower mortality risk was not seen in those drinking three or more glasses of wine a day.
- 3SUN cohort: no significant associations with cardiovascular disease; for mortality, HR 0.94 (95% CI 0.71-1.26) excluding wine and 0.54 (95% CI 0.28-1.04) including wine, both with intervals that include no effect.
- 4Pooling both cohorts, wine within the Mediterranean diet was associated with lower all-cause mortality (P = .01).
Limites et incertitude
- 1Analyses least vulnerable to abstainer bias, where non-drinkers may be unhealthier, were not significant, and neither were interaction terms for the wine item.
- 2Wine intake is captured by one questionnaire item with a cut-off of seven glasses per week, a crude measure, and comparing groups defined by it is observational even within a trial.
- 3The SUN estimates have wide confidence intervals that include no effect, and the cohorts differ in age and risk.
- 4The authors advise caution because of several non-significant results; based on the abstract only.
Mise en perspective
This does not show that wine improves health or that non-drinkers should start drinking; the evidence is associational and fragile. Alcohol carries other risks, so decisions about drinking belong with your clinician.
Vos données
A food log or diet-adherence score can show how close your eating is to a Mediterranean pattern, and tracking blood pressure, weight and lipids over time is more informative than any single food. Wearables cannot measure wine's effect on your heart risk.
Comprendre ce type de preuve
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background and aims
The benefits of the Mediterranean diet (MedDiet) are well established. However, one component, wine, remains controversial. This study assessed the association between MedDiet (with or without wine consumption) and major cardiovascular disease (CVD) or all-cause mortality.
Methods
The PREDIMED trial included 7447 high-risk participants. Adherence to MedDiet was measured using a validated 14-item questionnaire, including one item on wine (cut-off: seven glasses/week). The CVD events were recorded over a 4.8-year follow-up, while all-cause mortality was tracked for 17 years. A younger Spanish cohort (the SUN project), including 23,133 participants followed up for 22 years, was also evaluated.
Results
In PREDIMED, compared with poor compliers with MedDiet (excluding wine), good compliers (excluding wine), had a multivariable-adjusted hazard ratio (HR) of 0.84 [95% confidence interval (CI) 0.61-1.15] for CVD. For good compliers with MedDiet (including wine), the HR for CVD was 0.55 (95% CI 0.36-0.83). For all-cause mortality, MedDiet compliers (excluding wine) had HR of 0.77 (95% CI 0.68-0.87), which was 0.67 (95% CI 0.57-0.78) for MedDiet compliers (including wine). In exploratory dose-response analyses, reduced risk for death was not present in PREDIMED participants who drank three or more glasses of wine/day. Additionally, analyses least vulnerable to threats of abstainer bias were not significant and neither were multiplicative interaction terms for the wine item in the questionnaire. In the SUN cohort, no significant associations were observed between MedDiet compliance, wine, and CVD. However, for all-cause mortality, the HR was 0.94 (95% CI 0.71-1.26) for MedDiet compliers (excluding wine) and 0.54 (95% CI 0.28-1.04) for MedDiet compliers (including wine). When pooling both cohorts, wine consumption within the MedDiet was associated with lower all-cause mortality (P = .01).
Conclusions
In PREDIMED, moderate wine consumption, as part of the MedDiet, appeared to be associated with lower mortality and CVD risk. Some non-significant associations and interactions advise caution in interpretation of these findings.
Sources et attribution
Wine consumption, Mediterranean diet, and cardiovascular risk in two Spanish cohorts.
Martínez-González MA, Bes-Rastrollo M, Sayon-Orea C, Ruiz-Canela M, Timiraos J, Toledo E, Sorlí JV, Salas-Salvado J, Gómez-Gracia E, Fiol M, Shröeder H, Lapetra J, Serra-Majem L, Pintó X, Barbería-Latasa M, Ros E, Babio N, Ortega C, de la Torre R, Lamuela-Raventos RM, Estruch R.
European heart journal · 2026-07-01
DOI: 10.1093/eurheartj/ehaf1081 ↗PubMed · 41667089 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

